In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...
The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...
Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...
Two men, aged 18 and 19, were arrested a short time after the incident. A third man, aged 19, was arrested later at an address in Lisburn . All three were detained on suspicion of attempted murder ...
Semiglucagon-like peptide (GLP-1) injections for diabetes and weight loss surged in popularity over the last three years, and patient demand has continually outpaced supply by manufacturers like Eli ...
Denmark is home to Novo Nordisk NVO, the company behind Ozempic and Wegovy, two of the most in ... pause on tariffs against Mexico and Canada after last-minute talks. Mexico agreed to deploy ...
After testing many pairs for our different glasses stories, we can also recommend Felix Gray for blue light glasses and Peepers for readers. The best glasses for men come in a variety of fits and ...
Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss. According to data from the NHS' Open Prescribing service, semaglutide ...
Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year. The Danish pharmaceutical company has ...